UK health stocks advanced as Europe's two largest drugmakers, Glaxo and Astra, announced higher earn...
UK health stocks advanced as Europe's two largest drugmakers, Glaxo and Astra, announced higher earnings than forecasted.
The benchmark FTSE 100 ended the day slightly up with 2.3 points, or 0.06%, to 3,930.10, and the FTSE All-Share Index gained 3.7 points, or 0.20%, to 1,894.21 at the close.
The FTSE 100 has advanced 8.8% in April, the biggest monthly gain since September 1997, led by insurance companies and banks.
In addition, the FTSE All-Share Index has gained 9.1% in April, the largest monthly increase in more than a decade.
Healthcare group Amersham gained 24.5p, or 6%, to 446 after announcing good strength in the first three months of the year.
Pharmaceuticals groups also advanced.
Astra rose 69p to 2445p after reporting rising sales and Glaxo's gained 22p to 1251p as demand for its asthma drug Seretide increased sales.
Closing on a positive note was also automotive and industrial engineering group Tomkins that gained 8p to 213p - after it received a £143 million agreement to buy Canadian-based Stackpole.
Meanwhile, it was a darker day for banks as Royal Bank of Scotland stayed unchanged at 1644p, Barclays fell with 9.75p to 433.25p, and Lloyds TSB shed 5p to 416.5p.
In New York the Dow Jones Industrial Average is currently down 8.76 points to 8,494.23, and the Nasdaq is also down with 4.88 points to 1,466.42.
Alzheimer’s is the most common cause of dementia
Total of 72 accredited firms
23% fall since Q1
Achievements, charity work and other happy snippets
Including advice firm Chadkirk WM